(Q51026567)

27 March 2018

title

Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma. (English)

1 reference

27 March 2018

author name string

Mario Witkowski

1

1 reference

27 March 2018

Hans Christian Spangenberg

2

1 reference

27 March 2018

Christoph Neumann-Haefelin

3

1 reference

27 March 2018

Nico Büttner

4

1 reference

27 March 2018

Ekaterina Breous

5

1 reference

27 March 2018

Nadine Kersting

6

1 reference

27 March 2018

Oliver Drognitz

7

1 reference

27 March 2018

Ulrich T Hopt

8

1 reference

27 March 2018

Hubert E Blum

9

1 reference

27 March 2018

Nasser Semmo

10

1 reference

27 March 2018

Robert Thimme

11

1 reference

27 March 2018

language of work or name

English

0 references

publication date

25 March 2011

1 reference

27 March 2018

International Journal of Cancer

published in

1 reference

27 March 2018

volume

129

1 reference

27 March 2018

issue

9

1 reference

27 March 2018

page(s)

2171-2182

1 reference

27 March 2018

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration.

cites work

1 reference

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice

21 January 2018

1 reference

Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein

21 January 2018

1 reference

Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma

21 January 2018

1 reference

Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer

21 January 2018

1 reference

Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma.

21 January 2018

1 reference

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

21 January 2018

1 reference

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

21 January 2018

1 reference

Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

21 January 2018

1 reference

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

21 January 2018

1 reference

Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells

21 January 2018

1 reference

Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of disease

21 January 2018

1 reference

Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.

21 January 2018

1 reference

Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection

21 January 2018

1 reference

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection

21 January 2018

1 reference

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

21 January 2018

1 reference

Cytomegalovirus (CMV)-specific cellular immune responses.

21 January 2018

1 reference

Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children.

21 January 2018

1 reference

AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients

21 January 2018

1 reference

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

The size of the viral inoculum contributes to the outcome of hepatitis B virus infection

21 January 2018

1 reference

Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo

21 January 2018

1 reference

Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma.

21 January 2018

1 reference

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

21 January 2018

1 reference

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Analysis of CD4+ T-Cell Responses to a Novel -Fetoprotein-Derived Epitope in Hepatocellular Carcinoma Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25866

1 reference

27 March 2018

1 reference

27 March 2018